Taken together, these studies indicate that type XVII collagen is essential for maintaining cancer cells in cell cycle arrest, but after treatment with chemotherapy and thus shedding of type XVII collagen, dormant cancer cells start proliferating through FAK-YAP activation leading to tumor regrowth [43]. Here, PTK2 is linked to neoplasm.